Please login to the form below

Not currently logged in
Email:
Password:

RMS

This page shows the latest RMS news and features for those working in and with pharma, biotech and healthcare.

Roche's MS drug Ocrevus awarded priority review by FDA

Roche's MS drug Ocrevus awarded priority review by FDA

Roche is seeking a licence for the drug to treat both forms of MS - relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) -which respond poorly to current therapies. ... In the Opera I and II clinical trials for RMS,

Latest news

  • Sanofi Genzyme launches multiple sclerosis awareness campaign Sanofi Genzyme launches multiple sclerosis awareness campaign

    The vs.MS website also hosts videos, educational modules and the results of a global survey of people living with relapsing MS (RMS) in order to provide the MS community with ... The RMS survey questioned 1, 500 people and their care partners across

  • India's Supreme Court wants tighter clinical trial regulation India's Supreme Court wants tighter clinical trial regulation

    The Indian government needs to do more to stop illegal, unregulated clinical trials, according to Supreme Court judge Justice RM Lodha.

  • Oral agent meets MS trial primary endpoint

    Teriflunomide, a novel oral disease modifier under investigation by sanofi-aventis (S-A) for the treatment of relapsing multiple sclerosis (RMS), has been shown in the phase III TEMSO trial to ... TOWER and TENERE, two other phase III trials of

  • Regulatory affairs award winners

    The Innovation category was won by the company Samarind RMS, which built on the success of its corporate Windows regulatory software to create Samarind RMS On Demand, a tracking database and

  • Interferon phase III study commences

    Biogen Idec has announced the start of a phase III trial to evaluate the efficacy and safety of PEGylated Interferon beta-1a in patients with relapsing multiple sclerosis (RMS). ... Interferon beta-1a has been successfully used to treat patients with RMS

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics